Published by Josh White on 4th January 2023
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics announced on Wednesday that its subsidiary Tetris Pharma has launched 'Ogluo', or glucagon prefilled autoinjector pens, as a treatment for severe hypoglycaemia in children and adults living with diabetes in Austria.
URL: http://www.digitallook.com/dl/news/story/33214091/...